| Issue Date | Title | Author(s) |
| 25-May-2023 | Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study | Wei, Shanshan; Liao, Jiping; Xue, Tao; Yu, Kunyao; Fu, Xiuhua; Wang, Ruiying; Dang, Xiaomin; Zhang, Cheng; Qiao, Hua; Jiang, Shujuan; Xiao, Jianhong; Dong, Lixia; Yin, Jinzhi; Yan, Xixin; Jia, Weihua; Zhang, Guifang; Chen, Rui; Zhou, Bo; Song, Beibei; Li, Jing; Yin, Mengyu; Zhang, Lina; Xie, Liping; Dong, Shaochen; Sun, Jian; Gao, Peng; Miao, Bifang; Li, Wei; He, Lan; Ning, Qian; Zhao, Limin; Liu, Hengyi; Cao, Han; Wang, Guangfa |
| 25-May-2023 | Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study | Wei, Shanshan; Liao, Jiping; Xue, Tao; Yu, Kunyao; Fu, Xiuhua; Wang, Ruiying; Dang, Xiaomin; Zhang, Cheng; Qiao, Hua; Jiang, Shujuan; Xiao, Jianhong; Dong, Lixia; Yin, Jinzhi; Yan, Xixin; Jia, Weihua; Zhang, Guifang; Chen, Rui; Zhou, Bo; Song, Beibei; Li, Jing; Yin, Mengyu; Zhang, Lina; Xie, Liping; Dong, Shaochen; Sun, Jian; Gao, Peng; Miao, Bifang; Li, Wei; He, Lan; Ning, Qian; Zhao, Limin; Liu, Hengyi; Cao, Han; Wang, Guangfa |
| Jun-2020 | Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial | Su, Jinmei; Li, Mengtao; He, Lan; Zhao, Dongbao; Wan, Weiguo; Liu, Yi; Xu, Jianhua; Xu, Jian; Liu, Huaxiang; Jiang, Lindi; Wu, Huaxiang; Zuo, Xiaoxia; Huang, Cibo; Liu, Xiumei; Li, Fen; Zhang, Zhiyi; Liu, Xiangyuan; Dong, Lingli; Li, Tianwang; Chen, Haiying; Li, Jingyang; He, Dongyi; Lu, Xin; Huang, Anbin; Tao, Yi; Wang, Yanyan; Zhang, Zhuoli; Wei, Wei; Li, Xiaofeng; Zeng, Xiaofeng |
| Sep-2020 | Development and formulation of the classification criteria for osteoarthritis | Huang, Cibo; Zhang, Zhiyi; Chen, Yaolong; Zhang, Yue; Xing, Dan; Zhao, Like; Lin, Jianhao; Mei, Yifang; Lin, Hsiao-Yi; Zheng, Yi; Tsai, Wei-Chung; Liu, Shengyun; Jiang, Quan; Liu, Yi; Chen, Jinwei; Ye, Zhizhong; Chen, Min; Chen, Yingjuan; Chu, Cong-Qiu; Gao, Ming; He, Lan; Lin, Jin; Wu, Lijun; Xu, Jianhua; Yang, Pinting; Zhang, Xuewu; Jiang, Qing; Lei, Guanghua; Li, Mengtao; Yang, Wanling; Gu, Xin; Zhou, Yixin; He, Dongyi; Liu, Wei; Zhang, Weiya; Ding, Changhai; Zeng, Xiaofeng |
| 2016 | Dietary intake and risk of rheumatoid arthritis-a cross section multicenter study | He, Jing; Wang, Yu; Feng, Min; Zhang, Xia; Jin, Yue-Bo; Li, Xue; Su, Lin-Chong; Liu, Shuang; Wang, Ai-Xue; Chen, Xiao-Mei; Wu, Li-Jun; Yu, Xiao-Xia; Xu, Ning; Liu, Xiang-Yuan; Yan, Hui-Ming; Wang, Yong-Fu; Jia, Bin; Li, Jun-Fang; Tao, Jie-Mei; Zhang, Feng-Xiao; Yu, Ping; Cui, Liu-Fu; Yang, Jing; Li, Zhen-Bin; Xie, Jian-Li; Wei, Ping; Sun, Wen-Wen; Gong, Lu; Cheng, Yong-Jing; Huang, Ci-Bo; Wang, Xiao-Yuan; Wang, Yi; Guo, Hui-Fang; Jin, Hong-Tao; Liu, Xia; Wang, Guo-Chun; Wang, Yan-Hua; He, Lan; Zhao, Yi; Li, Xiao-Xia; Zhang, Yan; Guo, Jian-Ping; Li, |
| Mar-2023 | Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study | Ye, Hua; Liu, Shengyun; Xu, Jian; Chai, Kexia; He, Dongyi; Fang, Yongfei; Xie, Qibing; Liu, Huaxiang; Liu, Ying; Hua, Bingzhu; Hu, Jiankang; Zhang, Zhiyi; Zhou, Mingxuan; Zhao, Dongbao; Li, Yan; Jiang, Zhenyu; Wang, Meimei; Li, Jingyang; Zhang, Zhuoli; Li, Xiaomei; Li, Yang; Sun, Erwei; Bi, Liqi; Wei, Wei; Tie, Ning; He, Lan; Huang, Xiangyang; Zhang, Yan; Huang, Qingchun; Wang, Xiaofei; Liu, Xiangyuan; Li, Jing; Su, Yin |
| Oct-2020 | Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition) | Zhang, Zhiyi; Huang, Cibo; Jiang, Quan; Zheng, Yi; Liu, Yi; Liu, Shengyun; Chen, Yingjuan; Mei, Yifang; Ding, Changhai; Chen, Min; Gu, Xin; Xing, Dan; Gao, Min; He, Lan; Ye, Zhizhong; Wu, Lijun; Xu, Jianhua; Yang, Pinting; Zhang, Xuewu; Zhang, Yue; Chen, Jinwei; Lin, Jin; Zhao, Like; Li, Mengtao; Yang, Wanling; Zhou, Yixin; Jiang, Qing; Chu, Cong-Qiu; Chen, Yaolong; Zhang, Weiya; Tsai, Wei-Chung; Lei, Guanghua; He, Dongyi; Liu, Wei; Fang, Yongfei; Wu, Darong; Lin, Jianhao; Wei, Cheng-Chung; Lin, Hsiao-Yi; Zeng, Xiaofeng |
| 14-Mar-2025 | Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial | Dong, Zheyi; Luo, Ping; Sun, Shiren; Ni, Zhaohui; He, Yani; Huang, Xiangyang; Liu, Zhangsuo; Wu, Zhenbiao; Zhang, Xinzhou; Liao, Yunhua; Zhao, Jianhong; Lin, Hongli; Zhang, Xiao; Fu, Rongguo; Ding, Guohua; Xu, Yan; Wang, Lihua; Xiao, Yuefei; Shi, Shumei; Zuo, Xiaoxia; Li, Zhanguo; Qiao, Li; Wang, Rong; Li, Wenge; Wan, Jianxin; Li, Ying; Guan, Tianjun; Deng, Xiaoli; Wu, Xiaoyan; Zheng, Hongguang; Chen, Jianghua; He, Lan; Yamaguchi, Seika; Wang, Hua; Cai, Guang-yan; Zhang, Li; Chen, Xiangmei |
| 2019 | A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PA | Zeng, Xiaofeng; Wang, Yongfu; Jiang, Zhenyu; Zhang, Zhuoli; He, Lan; Zhang, Xiao; Lu, Xin; Liu, Xiumei; Xu, Jian; Huang, Cibo; Liu, Rui; Zuo, Xiaoxia; Zhao, Baozeng; Qiu, Wenting; Chai, Katherine; Guo, Xinjun; Zhang, Xin; Liu, Eugene; Luk, Alvin; Jiang, Weidong; Liu, Scott; Hu, Pei; Chen, Xia |
| 2017 | Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study | Bi, Liqi; Li, Yuhui; He, Lan; Xu, Huji; Gu, Jieruo; Wang, Guochun; Zhang, Zhiyi; Liu, Yi; Boehnlein, Marion; Dunkel, Jochen; Shao, Jing; Harris, Kristina; Li, Zhanguo |
| 2015 | TRIM30 alpha Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING | Wang, Yanming; Lian, Qiaoshi; Yang, Bo; Yan, Shanshan; Zhou, Haiyan; He, Lan; Lin, Guomei; Lian, Zhexiong; Jiang, Zhengfan; Sun, Bing |
| 2017 | The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study | An, Yuan; Liu, Tian; He, Dongyi; Wu, Lijun; Li, Juan; Liu, Yi; Bi, Liqi; Zhou, Bin; Lin, Changsong; He, Lan; Liu, Xiangyuan; Li, Xiaofeng; Yang, Niansheng; Zhang, Zhuoli; Song, Hui; Wei, Wei; Liu, Jing; Bi, Yu; Li, Zhanguo |
